Russia’s state-run, non-profit Rosnano will invest some 1.2 billion rubles in developing treatment for AIDS, hepatitis and cancer of the pancreas, the corporation said on Tuesday.

Read the original:
Russia to invest $40 million in developing AIDS, cancer treatment